Articles tagged with "Chemistry"

Sort by

Cannabis use for menopause symptom management

September 29, 2020
As legislation relaxes regarding cannabis, it is being used to manage numerous chronic health conditions and mood symptoms. A new study indicates that a growing number of women are either...

Diabetes-in-a-dish model uncovers new insights

September 4, 2020
Using cells taken from patients with type 2 diabetes and new techniques to convert them into specialised precursors of muscle cells, researchers have developed a novel 'disease-in-a-dish' model to study...

Ensuring ‘fair and equitable’ distribution of COVID-19 vaccines

September 4, 2020
When effective COVID-19 vaccines are developed, their supply will inevitably be scarce. The World Health Organization (WHO), global leaders, and vaccine producers are already facing the question of how to...

First rapid breath test for Coronavirus trialled

September 4, 2020
Canterbury-based technology firm ANCON Medical (‘Ancon’) announces the trial of its Nanotechnology Biomarker Tagging (NBT) system, to provide a breath test to diagnose Coronavirus in 10 -15 minutes. The system,...

New Leicestershire-based COVID-19 testing ‘Lighthouse Lab’

September 4, 2020
A new ‘Lighthouse Lab’ facility will be established in Leicestershire to increase the UK’s COVID-19 testing capacity, in an investment creating 400 jobs.

Medicines Discovery Catapult creates a worldwide virtual biobank

August 18, 2020
Today, Medicines Discovery Catapult (MDC) announce the rapid expansion of its Biosamples supply network, creating one of the largest virtual biobanks worldwide accessible to life science innovators.

AI stratification significantly improves treatment outcomes for COVID-19 patients

August 11, 2020
AN EIT Health project demonstrates early positive results on improving treatment outcomes of patients hospitalised with severe COVID-19 (as part of the EIT’s Crisis Response Initiative, this project directly contributes...

Computational model could help translate drugs from animal studies to human

August 5, 2020
About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn's disease, end up becoming resistant or unresponsive to it. Scientists might be able to...

Pin It on Pinterest